CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Revenue, 2025
- $761M
- YoY, 2025
- +12.8%
- 5-year CAGR
- +16.6%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $761M | +12.8% |
| 2024 | $675M | +39.9% |
| 2023 | $482M | +20.0% |
| 2022 | $402M | +9.8% |
| 2021 | $366M | +3.4% |
| 2020 | $354M | +15.5% |
| 2019 | $306M | +22.0% |
| 2018 | $251M | +57.8% |
| 2017 | $159M | +95.8% |
| 2016 | $81M | — |
| 2009 | $29K | — |